APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome (vol 67, pg 24, 2014)NEUROBIOLOGY OF DISEASEIF5.62020-05-010OAAI
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorderHUMAN MOLECULAR GENETICSIF3.22018-02-2055OAAI
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorderHUMAN MOLECULAR GENETICSIF3.22016-07-2779OAAI
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorderNEUROBIOLOGY OF DISEASEIF5.62015-10-0163PREAI
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signalingNEUROBIOLOGY OF DISEASEIF5.62014-10-01117OAAI
APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndromeNEUROBIOLOGY OF DISEASEIF5.62014-07-0136PREAI
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse modelBRAINIF11.72013-12-1067OA